The effect of nifurtimox in acute Chagas' infection.
D000208:Acute Disease; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001835:Body Weight / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D014355:Chagas Disease / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003499:Cyclic S-Oxides / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009581:Nitrofurans / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D012698:Serologic Tests; D013843:Thiazines / Q000627:therapeutic use*
D003499:Cyclic S-Oxides; D009581:Nitrofurans; D010919:Placebos; D013843:Thiazines